DOI QR코드

DOI QR Code

Antiproliferative Effects of Crocin in HepG2 Cells by Telomerase Inhibition and hTERT Down-Regulation

  • Noureini, Sakineh Kazemi (Department of Biology, Faculty of Science, Hakim Sabzevari University) ;
  • Wink, Michael (Department of Biology, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University)
  • 발행 : 2012.05.30

초록

Crocin, the main pigment of Crocus sativus L., has been shown to have antiproliferative effects on cancer cells, but the involved mechanisms are only poor understood. This study focused on probable effect of crocin on the immortality of hepatic cancer cells. Cytotoxicity of crocin ($IC_{50}$ 3 mg/ml) in hepatocarcinoma HepG2 cells was determined after 48 h by neutral red uptake assay and MTT test. Immortality was investigated through quantification of relative telomerase activity with a quantitative real-time PCR-based telomerase repeat amplification protocol (qTRAP). Telomerase activity in 0.5 ${\mu}g$ protein extract of HepG2 cells treated with 3 mg/ml crocin was reduced to about 51% as compared to untreated control cells. Two mechanisms of inhibition, i.e. interaction of crocin with telomeric quadruplex sequences and down regulation of hTERT expression, were examined using FRET analysis to measure melting temperature of a synthetic telomeric oligonucleotide in the presence of crocin and quantitative real-time RT-PCR, respectively. No significant changes were observed in the $T_m$ telomeric oligonucleotides, while the relative expression level of the catalytic subunit of telomerase (hTERT) gene showed a 60% decrease as compared to untreated control cells. In conclusion, telomerase activity of HepG2 cells decreases after treatment with crocin, which is probably caused by down-regulation of the expression of the catalytic subunit of the enzyme.

키워드

참고문헌

  1. Abdullaev FI, Espinosa-Aguirre JJ (2004). Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev, 28, 426-32. https://doi.org/10.1016/j.cdp.2004.09.002
  2. Abdullaev FI, River$A^{3}$n-Negrete L, Caballero-Ortega H, et al (2003). Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). Toxicol In Vitro, 17, 731-6. https://doi.org/10.1016/S0887-2333(03)00098-5
  3. Abdullaev JF, Caballero-Ortega H, Riveron-Negrete L, et al (2002). In vitro evaluation of the chemopreventive potential of saffron. Rev Invest Clin, 54, 430-6.
  4. Akhondzadeh S, Fallah-Pour H, Afkham K, et al (2004). Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression, A pilot doubleblind randomized trial. BMC Complementary Alternative Med, 4, 12, https://doi.org/10.1186/1472-6882-4-12
  5. Aung HH, Wang CZ, Ni M, et al (2007). Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol, 29, 175-80.
  6. Bakshi H, Sam S, Rozati R, et al (2010). DNA fragmentation and cell cycle arrest, A Hallmark of apoptosis induced by crocin from Kashmiri saffron in a human pancreatic cancer cell line. Asian Pacific J Cancer Prev, 11, 675-9.
  7. Bakshi HA, Sam S, Feroz A, et al (2009). Crocin from Kashmiri saffron (Crocus sativus) induces in vitro and in vivo xenograft growth inhibition of Dalton's lymphoma (DLA) in mice. Asian Pac J Cancer Prev, 10, 887-90.
  8. Blackburn E, Greider C (1995). Telomeres. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
  9. Blackburn EH (2001). Switching and signaling at the telomere. Cell, 106, 661-73. https://doi.org/10.1016/S0092-8674(01)00492-5
  10. Borenfreund E, Bbich H, Martin-Alguacil N, (1990). Rapid chemosensitivity assay with human normal and tumor cells in vitro. In Vitro Cell Dev Biol, 26, 1030-4. https://doi.org/10.1007/BF02624436
  11. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, 248-54. https://doi.org/10.1016/0003-2697(76)90527-3
  12. Chryssanthi DG, Lamari FN, Iatrou G, et al (2007). Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res, 27, 357-62.
  13. Damm K, Hemmann U, Garin-Chesa P, et al (2001). A highly selective telomerase inhibitor limiting human cancer cell proliferation. The EMBO J, 20, 6958-68. https://doi.org/10.1093/emboj/20.24.6958
  14. Ebrahim-Habibi MB, Amininasab M, Ebrahim-Habibi A, et al. (2010) Fibrillation of alpha-lactalbumin: effect of crocin and safranal, two natural small molecules from Crocus sativus. Biopolymers. 93, 854-65. https://doi.org/10.1002/bip.21477
  15. Escribano J, Alonso GL, Coca-Prados M, et al (1996). Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett, 100, 22-30.
  16. Ghadrdoost B, Vafaei AA, Rashidy-Pour A, et al (2011) Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. Eur J Pharmacol, 667, 222-9. https://doi.org/10.1016/j.ejphar.2011.05.012
  17. Gunes C, Lichtsteiner S, Vasserot AP, et al (2000). Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res, 60, 2116-21.
  18. Hahn WC, Stewart SA, Brooks MW, et al (1999). Inhibition of telomerase limits the growth of human cancer cells. Nature Med, 5, 1164-70. https://doi.org/10.1038/13495
  19. Hariri AT, Moallem SA, Mahmoudi M, et al (2011). The effect of crocin and safranal, constituents of saffron, against subacute effect of diazinon on hematological and genotoxicity indices in rats. Phytomedicine, 18, 499-504. https://doi.org/10.1016/j.phymed.2010.10.001
  20. Hiyama E, Yokoyama T, Tatsumoto N, et al (1995). Telomerase activity in gastric cancer. Cancer Res, 55, 3258-62.
  21. Hosseinzadeh H, Sadeghnia HR, Ghaeni FA, et al (2012) Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats. Phytother Res, 26, 381-6.
  22. Hou M, Dawei X, Bjorkholm M, et al (2001). Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin Chem, 47, 519-24
  23. Huffman KE, Levene SD, Tesmer VM, et al (2000). Telomere shortening is proportional to the size of the G-rich telomeric 3'-overhang. J Biol Chem, 26, 19719-22.
  24. Kazemi Noureini S, Ziaee AA, Rastegar-Jazii F, et al (2004). Telomerase activity in Iranian patients with esophageal squamous cell carcinoma. Med J Islamic Republic Iran, 2, 147-52.
  25. Kazemi Noureini S, Wink M (2009). Transcriptional down regulation of hTERT and induction of senescence in HepG2 cells by the benzophenanthridine alkaloid chelidonine. World J Gastroenterol, 15, 3603-10. https://doi.org/10.3748/wjg.15.3603
  26. Kondo S, Kondo Y, Li G, et al (1998). Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene, 16, 3323-30. https://doi.org/10.1038/sj.onc.1201885
  27. Konoshima T, Takasaki M (2003). Anti-carcinogenic activities of natural pigments from beet root and saffron. Foods Food Ingredients J, 208, 615-22.
  28. Li S, Rosenberg J, Donjacour A, et al (2004). Inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase shortinterfering RNA. Cancer Res, 64, 4833-40. https://doi.org/10.1158/0008-5472.CAN-04-0953
  29. Ludwig A, Saretzki G, Holm PS, et al (2001). Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Cancer Res, 61, 3053-61.
  30. Mehri S, Abnous K, Mousavi SH, et al (2012) Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells. Cell Mol Neurobiol, 32, 227-35. https://doi.org/10.1007/s10571-011-9752-8
  31. Mergny JL, Lacroix L, Teulade-Fichou MP, et al (2001). Telomerase inhibitors based on quadruplex ligands selected by a fluorescent assay. Proc Natl Acad Sci USA, 98, 3062-7. https://doi.org/10.1073/pnas.051620698
  32. Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-63. https://doi.org/10.1016/0022-1759(83)90303-4
  33. Mousavi SH, Moallem SA, Mehri S, et al (2011) Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form. Pharm Biol, 49, 1039-45. https://doi.org/10.3109/13880209.2011.563315
  34. Nair SC, Kurumboor SK, Hasegawa JH (1995). Saffron chemoprevention in biology and medicine, a review. Cancer Biother, 10, 257-64. https://doi.org/10.1089/cbr.1995.10.257
  35. Nosrati M, Li S, Bagheri S, et al (2004). Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Clinical Cancer Res, 10, 4983-90. https://doi.org/10.1158/1078-0432.CCR-04-0134
  36. Ochiai T, Shimeno H, Mishima K, et al (2006). Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim Biophys Acta, 1770, 578-84.
  37. Papandreou MA, Kanakis CD, Polissiou MG, et al (2006). Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem, 54, 8762-8. https://doi.org/10.1021/jf061932a
  38. Pham TQ, Cormier F, Farnworth E, et al (2000). Antioxidant properties of crocin from Gardenia jasminoides Ellis and study of the reactions of crocin with linoleic acid and crocin with oxygen. J Agric Food Chem, 48, 1455-61. https://doi.org/10.1021/jf991263j
  39. Schmidt M, Betti G, Hensel A (2007). Saffron in phytotherapy, pharmacology and clinical uses. Wien Med Wochenschr, 157, 315-9. https://doi.org/10.1007/s10354-007-0428-4
  40. Shay JW, Wright WE (2002). Telomerase, a target for cancer therapeutics. Cancer Cell, 2, 257-65. https://doi.org/10.1016/S1535-6108(02)00159-9
  41. Smith LL, Coller HA, Roberts JM (2003). Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol, 5, 474-9. https://doi.org/10.1038/ncb985
  42. Stewart CR (1968). Broadening by acridine orange of the thermal transition of DNA. Biopolymers, 6, 1737-43. https://doi.org/10.1002/bip.1968.360061208
  43. Sun J, Xu X, Ni C, et al (2011). Crocin inhibits proliferation and nucleic acid synthesis and induces apoptosis in the human tongue squamous cell carcinoma cell line Tca8113. Asian Pac J Cancer Prev, 12, 2679-83.
  44. Wink M, Van Wyk BE (2008). Mind-Altering and Poisonous Plants of the World , Briza Publications, Pretoria, Medpharm Publishers, Germany, Timber Press, USA.
  45. Yi-hsin HSU, Jing-jer LIN (2005). Telomere and telomerase as targets for anti-cancer and regeneration therapies. Acta Pharmacologica Sinica, 26, 513-8. https://doi.org/10.1111/j.1745-7254.2005.00098.x
  46. Zheng YQ, Liu JX, Wang JN, et al (2006). Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia. Brain Res, 1138, 86-94.

피인용 문헌

  1. Dietary Crocin Inhibits Colitis and Colitis-Associated Colorectal Carcinogenesis in Male ICR Mice vol.2012, pp.1741-4288, 2012, https://doi.org/10.1155/2012/820415
  2. Crocin Triggers the Apoptosis Through Increasing the Bax/Bcl-2 Ratio and Caspase Activation in Human Gastric Adenocarcinoma, AGS, Cells vol.32, pp.2, 2013, https://doi.org/10.1089/dna.2012.1866
  3. Antiproliferative Effect of the Isoquinoline Alkaloid Papaverine in Hepatocarcinoma HepG-2 Cells — Inhibition of Telomerase and Induction of Senescence vol.19, pp.8, 2014, https://doi.org/10.3390/molecules190811846
  4. Targeting Human Telomerase Reverse Transcriptase by a Simple siRNA Expression Cassette in HepG2 Cells vol.15, pp.3, 2015, https://doi.org/10.5812/hepatmon.24343
  5. Dose-Dependent Cytotoxic Effects of Boldine in HepG-2 Cells—Telomerase Inhibition and Apoptosis Induction vol.20, pp.3, 2015, https://doi.org/10.3390/molecules20033730
  6. -Methylurea-Induced Breast Cancer in Rats vol.34, pp.11, 2015, https://doi.org/10.1089/dna.2015.2951
  7. Natural compounds for pediatric cancer treatment vol.389, pp.2, 2016, https://doi.org/10.1007/s00210-015-1191-5
  8. A comprehensive review on anticancer mechanisms of the main carotenoid of saffron, crocin pp.00223573, 2017, https://doi.org/10.1111/jphp.12776
  9. Antiproliferative and Proapoptotic Effects of Crocin Combined with Hyperthermia on Human Breast Cancer Cells vol.35, pp.7, 2016, https://doi.org/10.1089/dna.2015.3208
  10. Telomerase Inhibitors from Natural Products and Their Anticancer Potential vol.19, pp.1, 2018, https://doi.org/10.3390/ijms19010013
  11. Antiproliferative Activity of Crocin Involves Targeting of Microtubules in Breast Cancer Cells vol.7, pp.1, 2017, https://doi.org/10.1038/srep44984
  12. Drug-DNA interaction, A joint DFT-D3/MD study on the Safranal as an anticancer and DNA nanostructure model pp.1480-3291, 2018, https://doi.org/10.1139/cjc-2018-0126
  13. L. Causes a Non Apoptotic Calpain Dependent Death in C6 Rat Glioma Cells, Exhibiting a Synergistic Effect with Temozolomide pp.1532-7914, 2019, https://doi.org/10.1080/01635581.2018.1506493
  14. Telomerase Inhibition by a New Synthetic Derivative of the Aporphine Alkaloid Boldine vol.19, pp.4, 2018, https://doi.org/10.3390/ijms19041239